4:36 PM ET
10-Q
Financial Results
AIM ImmunoTech Q3 2026 Results: Net Loss of $3.14M, Loss Narrows
AIM ImmunoTech reported a net loss of $9.95 million for the nine months ended September 30, 2026, compared to $9.78 million in the prior year. The company significantly strengthened its balance sheet through equity offerings and warrant exercises, increasing total assets to $9.75 million and achieving a positive stockholders' equity of $7.08 million.
- Key figure
- Net loss $3.14M